These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23425181)

  • 21. Variable response to intravenous gamma-globulin therapy in a patient with autoimmune neutropenia, thrombocytopenia, and pemphigoid.
    Novak RM; Ou DW; Sulo RM; Chen YH
    South Med J; 1988 May; 81(5):653-5. PubMed ID: 3130663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunotherapy of high dose intravenous immunoglobulins: basic mechanisms of action and clinical implications].
    Korsak J; Kłos M
    Pol Arch Med Wewn; 2001 Nov; 106(5):1071-7. PubMed ID: 12026522
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-standing oral ulcers.
    Talhari C; Angerstein W; Becker J; Ruzicka T; Megahed M
    Lancet; 2005 Mar 12-18; 365(9463):1002. PubMed ID: 15767005
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment of linear IgA disease with salazosulphapyridine and intravenous immunoglobulins.
    Goebeler M; Seitz C; Rose C; Sitaru C; Jeschke R; Marx A; Bröcker EB; Zillikens D
    Br J Dermatol; 2003 Oct; 149(4):912-4. PubMed ID: 14616404
    [No Abstract]   [Full Text] [Related]  

  • 25. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linear immunoglobulin a bullous disease of childhood responsive to intravenous immunoglobulin monotherapy.
    Nanda A; Khawaja F; Nanda M; Al-Sabah H; Selim MK; Dvorak R; Alsaleh QA
    Pediatr Dermatol; 2012; 29(4):529-32. PubMed ID: 21906145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
    Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autoimmune blistering skin diseases: recent advances].
    Joly P
    Presse Med; 2010 Oct; 39(10):1040-1. PubMed ID: 20692800
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of intravenous immune globulin therapy.
    Spellberg B
    N Engl J Med; 1999 Jul; 341(1):57-8. PubMed ID: 10391765
    [No Abstract]   [Full Text] [Related]  

  • 30. The antiinflammatory IgG.
    Kaveri SV; Lacroix-Desmazes S; Bayry J
    N Engl J Med; 2008 Jul; 359(3):307-9. PubMed ID: 18635437
    [No Abstract]   [Full Text] [Related]  

  • 31. What is new in autoimmune vesicobullous disorders?
    Mahajan R; De D
    Indian J Dermatol Venereol Leprol; 2011; 77(4):407-12. PubMed ID: 21727687
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):927-47. PubMed ID: 22026362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Kaveri SV; Mouthon L; Kazatchkine MD
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):6-8. PubMed ID: 7964857
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2012 Jun; 147(3):259-67. PubMed ID: 22648327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune urticaria response to high-dose intravenous immunoglobulin.
    Klote MM; Nelson MR; Engler RJ
    Ann Allergy Asthma Immunol; 2005 Feb; 94(2):307-8. PubMed ID: 15765750
    [No Abstract]   [Full Text] [Related]  

  • 36. Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions.
    Alaibac M
    Front Immunol; 2018; 9():810. PubMed ID: 29720979
    [No Abstract]   [Full Text] [Related]  

  • 37. The pros and cons of intravenous immunoglobulin treatment in autoimmune nephropathy.
    Gonzalez-Gay MA
    Semin Arthritis Rheum; 2004 Dec; 34(3):573-4. PubMed ID: 15609260
    [No Abstract]   [Full Text] [Related]  

  • 38. Regression of white matter MRI abnormalities in nonvasculitic autoimmune inflammatory meningoencephalitis following intravenous immunoglobulin.
    Imperiale D; Guastamacchia G; Duca S; Appendino L; Marietti G; Romito A; Atzori C; Buffa C
    Eur Neurol; 2007; 57(4):244-5. PubMed ID: 17389804
    [No Abstract]   [Full Text] [Related]  

  • 39. Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole.
    Peterson JD; Chan LS
    Clin Exp Dermatol; 2007 Nov; 32(6):756-8. PubMed ID: 17868394
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders.
    Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L
    BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.